Home Cart Sign in  
Chemical Structure| 1309793-47-2 Chemical Structure| 1309793-47-2

Structure of (±)-CPSI-1306
CAS No.: 1309793-47-2

Chemical Structure| 1309793-47-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(±)-CPSI-1306 is an orally active macrophage migration inhibitory factor (MIF) antagonist.

Synonyms: CPSI-1306

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (±)-CPSI-1306

CAS No. :1309793-47-2
Formula : C15H16F2N2O3
M.W : 310.30
SMILES Code : FC1=CC=C(C2=NOC(CC(N3CCOCC3)=O)C2)C(F)=C1
Synonyms :
CPSI-1306
MDL No. :MFCD26792562
InChI Key :GUWOSEVHCSNYFK-UHFFFAOYSA-N
Pubchem ID :59723793

Safety of (±)-CPSI-1306

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MVT-1 0.5 and 2 μM 48 h CPSI-1306 significantly reduced the viability of TNBC cells and induced intrinsic apoptosis by altering mitochondrial membrane potential, cytochrome c release, and activation of different caspases. Cell Death Dis. 2020 Sep 17;11(9):774

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice MDA-MB-231 mammary fat pad xenograft model Oral 10 or 20 mg/kg Three times a week for 4 weeks CPSI-1306 treatment significantly reduced tumor volume and weight and inhibited lung metastasis. Histological analysis revealed a higher number of apoptotic cells in CPSI-1306-treated tumors compared to vehicle controls. Cell Death Dis. 2020 Sep 17;11(9):774
Skh-1 hairless mice UVB-induced squamous cell carcinoma model Oral 20 mg/kg 5 consecutive days before UVB exposure; or 10 weeks UVB exposure followed by 8 weeks CPSI-1306 treatment CPSI-1306 significantly reduced UVB-induced skin inflammation and squamous cell carcinoma development, decreased skin thickness and MPO activity, increased keratinocyte apoptosis and p53 expression, and reduced proliferation and DNA damage. Mol Cancer Res. 2014 Sep;12(9):1292-302

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.22mL

0.64mL

0.32mL

16.11mL

3.22mL

1.61mL

32.23mL

6.45mL

3.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories